Cerebral Vasospasm

Advances in vasospasm research.- Advances in vasospasm research.- Vasospasm pathogenies.- Pre-vasospasm: early brain injury.- Apoptotic markers in vasospasm after an experimental subarachnoid haemorrhage.- Cerebrospinal fluid soluble Fas and Fas ligand levels after aneurysmal subarachnoid haemorrhage.- Time course of oxyhemoglobin induces apoptosis in mice brain cells in vivo.- Inhibition of c-Jun N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis.- Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm.- Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics.- Vascular contractility changes due to vasospasm induced by periarterial whole blood and thrombocyte rich plasma.- Vasospasm biochemistry.- Vasospasm biochemistry.- The roles of cross-talk mechanisms in the signal transduction systems in the pathophysiology of the cerebral vasospasm after subarachnoid haemorrhage — what we know and what we do not know.- Subarachnoid hemorrhage induces upregulation of vascular receptors and reduction in rCBF via an ERK1/2 mechanism.- Effect of deferoxamine-activated hypoxia inducible factor-1 on the brainstem following subarachnoid haemorrhage.- Urgosedin downregulates mRNA expression of TNF-? in brain tissue of rats subjected to experimental subarachnoid haemorrhage.- Nucleotide-induced cerebral vasospasm in an in vivo mouse model.- Effects of ADPbetaS on purine receptor expression in mouse cerebral vasculature.- Vasospasm electrophysiology.- Electrophysiology of cerebral vasospasm.- Cellular basis of vasospasm: role of small diameter arteries and voltage-dependent Ca2+ channels.- Acute and chronic effects of oxyhemoglobin on voltage-dependent ion channels in cerebral arteries.- The effect of an intracisternal nimodipine slow-release system on cerebral vasospasm after experimental subarachnoid haemorrhage in the rat.- Cerebral vasospasm following subarachnoid haemorrhage is completely prevented by L-type calcium channel antagonist in human.- Vasospasm pharmacology.- Vasospasm pharmacology.- Endothelin-converting enzyme inhibitor versus cerebrovasospasm.- A pharmacokinetic study of clazosentan in patients with aneurysmal subarachnoid haemorrhage.- Pharmacokinetic and pharmacodynamic aspects of the interaction between clazosentan and nimodipine in healthy subjects.- Attenuation of intercellular adhesion molecule-1 and cerebral vasospasm in rabbits subjected to experimental subarachnoid haemorrhage by CGS 26303.- The effect of 17?-estradiol in the prevention of cerebral vasospasm and endothelin-1 production after subarachnoid haemorrhage.- Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.- An adenosine A1 receptor agonist preserves eNOS expression and attenuates cerebrovasospasm after subarachnoid haemorrhage.- Vasospasm molecular biology.- Gene transfer after subarachnoid hemorrhage: a tool and potential therapy.- Direct protein transduction method to cerebral arteries by using 11R: new strategy for the treatment of cerebral vasospasm after subarachnoid haemorrhage.- Endothelial nitric oxide synthase-11R protein therapy for prevention of cerebral vasospasm in rats: a preliminary report.- Microarray analysis of hemolysate-induced differential gene expression in cultured human vascular smooth muscle cells (HVSMC).- Vasospasm remodeling.- Role of vascular remodeling in cerebral vasospasm.- Possible role of tenascin-C in cerebral vasospasm after aneurysmal subarachnoid haemorrhage.- Ecdysterone-sensitive smooth muscle cell proliferation stimulated by conditioned medium of endothelial cells cultured with bloody cerebrospinal fluid.- The effect of oxyhemoglobin on the proliferation and migration of cultured vascular advential fibroblasts.- The effect of oxyhemoglobin on the proliferation and migration of cultured vascular smooth muscle cells.- Comparison of three measurement methods for basilar artery with neurological changes in rabbits subjected to experimental subarachnoid hemorrhage.- Vasospasm diagnostic.- Vasospasm diagnosis strategies.- Continuous evaluation of regional oxygen saturation in cerebral vasospasm after subarachnoid haemorrhage using INVOS®, portable near infrared spectrography.- Automated voxel-based analysis of brain perfusion SPECT for vasospasm after subarachnoid haemorrhage.- Angiographic scale for evaluation of cerebral vasospasm.- CT evaluation of late cerebral infarction after operation for ruptured cerebral aneurysm.- Elevated intracranial pressure or subarachnoid blood responsible for reduction in cerebral blood flow after SAH.- Magnetic resonance imaging in the canine double-haemorrhage subarachnoid haemorrhage model.- Perfusion/diffusion-weighted imaging protocol for the diagnosis of cerebral vasospasm and management of treatment after subarachnoid haemorrhage.- Diffusion and perfusion MRI findings with clinical correlation in patients with subarachnoid haemorrhage related vasospasm.- Correlation of end-tidal CO2 with transcranial Doppler flow velocity is decreased during chemoregulation in delayed cerebral vasospasm after subarachnoid haemorrhage — results of a pilot study.- A diagnostic flowchart, including TCD, Xe-CT and angiography, to improve the diagnosis of vasospasm critically affecting cerebral blood flow in patients with subarachnoid haemorrhage, sedated and ventilated.- Basilar artery vasospasm: diagnosis and grading by transcranial Doppler.- Predictive value of transcranial Doppler to detect clinical vasospasm in patients with aneurysmal subarachnoid haemorrhage.- Vasospasm medical treatment.- Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a meta-analysis of published data.- Hypomagnesemia after ruptured middle cerebral artery aneurysms: predictive factor and pathophysiological implication.- The role of magnesium sulfate in the treatment of vasospasm in patients with spontaneous subarachnoid haemorrhage.- Fasudil (a rho-kinase inhibitor) may specifically increase rCBF in spastic area.- Multimodality therapy for cerebral vasospasm after SAH: importance of intensive care and intraarterial injection of fasudil hydrochloride.- The effect of KMUVS-1 on experimental subarachnoid haemorrhage-induced cerebrovasospasm.- Role of statins in cerebral vasospasm.- Treatment of cerebral vasospasm with cilostazol in subarachnoid haemorrhage model.- Ecdysterone attenuates vasospasm following experimental subarachnoid haemorrhage in rabbits.- Vasospasm chemical surgery.- Clot-clearance rate in the sylvian cistern is associated with severity of cerebral vasospasm after subarachnoid haemorrhage.- Simultaneous head rotation and lumboventricular lavage in patients after severe subarachnoid haemorrhage: an initial analysis of the influence on clot clearance rate and cerebral vasospasm.- Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs.- Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm.- Prevention of symptomatic vasospasm — effect of continuous cisternal irrigation with urokinase and ascorbic acid.- Cisternal washing therapy for the prevention of cerebral vasospasm following SAH: analysis of 308 consecutive cases with Fisher group 3 SAH.- Surgical treatment.- Questionable value of decompressive craniectomy after severe aneurysmal subarachnoid haemorrhage.- Low incidence of cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a comparison between surgical repairs and endovascular coil occlusions.- Microsurgical treatment of unruptured intracranial aneurysms.- Coil embolization decrease the incidence of symptomatic vasospasm, except in patients with poor grade subarachnoid hemorrhage.- Endovascular therapy of cerebral vasospasm: two year experience with angioplasty and/or intraarterial administration of nicardipine and verapamil.- Utility of intra-arterial nimodipine for cerebral vasospasm.- Intra-arterial nicardipine successfully relieved post-subarachnoid hemorrhage cerebral vasospasm during aneurysm embolization: a case report.- Prognosis.- Evaluating the factors affecting cerebral vasospasm in patients after aneurysmal subarachonoid haemorrhage.- Is cerebral salt wasting after subarachnoid haemorrhage caused by bleeding?.- Relationship between the development of vasospasm after aneurysmal subarachnoid haemorrhage and the levels of dendroaspis natriuretic peptide in body fluids.- An abrupt fall in blood pressure in aneurysmal subarachnoid hemorrhage.- C-reactive protein might predict outcome in aneurysmal subarachnoid haemorrhage.- Factors affecting the incidence and severity of vasospasm after subarachnoid haemorrhage.- Basilar artery vasospasm: impact on outcome.- Change of management results in good-grade aneurysm patients.- Quantification of transient ischemic and metabolic events in patients after subarachnoid haemorrhage.- Other vasospasm.- Pediatric subarachnoid haemorrhage.- Childhood intracranial aneurysms.- Pediatric cerebral aneurysms: a report of 9 cases.- Intracranial aneurysms during childhood and puberty.- Vasospasm in traumatic brain injury.- Traumatic vasospasm.- Cerebral vasospasm in diffuse axonal injury patients.- The effects of nimopidine on platelet aggregation in severe head injury.- “Street drugs” and subarachnoid haemorrhage.